| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fingolimod | histone deacetylase 1 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| fingolimod | histone deacetylase 1 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| fingolimod | sphingosine-1-phosphate receptor 1 | NA | Successful target | TTD , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
7.58 | approved | agonist |
| fingolimod | sphingosine 1-phosphate receptor 1 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
7.58 | approved,investigational | modulator,agonist |
| fingolimod | sphingosine-1-phosphate receptor 1 | NA | Successful target | TTD , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
7.58 | approved | unknown |
| fingolimod | sphingosine 1-phosphate receptor 1 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
7.58 | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 1 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
7.58 | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 1 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
7.58 | approved,investigational | modulator,agonist |
| fingolimod | sphingosine-1-phosphate receptor 1 | NA | Successful target | TTD , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
7.58 | approved | agonist |
| fingolimod | sphingosine-1-phosphate receptor 1 | NA | Successful target | TTD , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
7.58 | approved | unknown |
| fingolimod | sphingosine 1-phosphate receptor 3 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 3 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 4 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 4 | small molecule | NA | drugbank | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | modulator |
| fingolimod | sphingosine 1-phosphate receptor 5 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Multiple Sclerosis Primary Progressive[MeSHID:D020528] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
11.93 | approved,investigational | modulator,agonist |
| fingolimod | sphingosine 1-phosphate receptor 5 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Respiratory Distress Syndrome Adult[MeSHID:D012128] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
11.93 | approved,investigational | modulator,agonist |
| click here to return to the previous page | ||||||||